A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
Purpose
The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID-19.
Condition
- SARS-CoV-2
Eligibility
- Eligible Ages
- Between 50 Years and 64 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Healthy and without underlying medical conditions that may put them at higher risk of experiencing severe outcomes of COVID-19, as determined by medical evaluation including medical history, physical examination, laboratory tests, and cardiac monitoring.
Exclusion Criteria
- History of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection within 3 months prior to enrollment. - Acutely ill or febrile within 72 hours prior to or at the Screening Visit or Day 1. - Receipt of any of the following: - COVID-19 vaccine within 3 months prior to enrollment, - Any licensed non COVID-19 vaccine within 28 days before or planned receipt within 28 days after the study intervention, except an influenza vaccine, which may be given 14 days before or after receipt of the study intervention, - Corticosteroids at ≥10 milligrams (mg)/day of prednisone or equivalent for >14 days in total within 90 days prior to Day 1 or is anticipating the need for corticosteroids at any time during the study or, - Systemic immunosuppressive treatment within 180 days prior to the Screening or is anticipating the need for systemic immunosuppressive treatment at any time during participation in the study. - Has donated ≥450 mL of blood products within 28 days prior to the Screening Visit or plans to donate blood products within 28 days post study injection. - Has participated in an investigational clinical study within 28 days prior to the Screening Visit based on the medical history interview or plans to do so while participating in this study. Note: Additional inclusion/exclusion criteria may apply, per protocol.
Study Design
- Phase
- Phase 4
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Prevention
- Masking
- Triple (Participant, Investigator, Outcomes Assessor)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental mRNA-1273 (Variant Formulation) |
Participants will receive a single intramuscular (IM) injection of mRNA-1273 on Day 1. |
|
|
Experimental mRNA-1283 (Variant Formulation) |
Participants will receive a single IM injection of mRNA-1283 on Day 1. |
|
|
Placebo Comparator Placebo |
Participants will receive a single IM injection of placebo on Day 1. |
|
Recruiting Locations
Birmingham, Alabama 35216
Cullman, Alabama 35055
Mobile, Alabama 36608
Mobile, Alabama 36608
Glendale, Arizona 85308
Mesa, Arizona 85213
Phoenix, Arizona 85006
Phoenix, Arizona 85044
Scottsdale, Arizona 85260
Tempe, Arizona 85283
Colton, California 92324
Garden Grove, California 92845
Huntington Park, California 90255
La Mesa, California 91942
Riverside, California 92503
Rolling Hills Estates, California 90274
San Bernardino, California 92408
San Diego, California 92103
Denver, Colorado 80238
Fort Collins, Colorado 80525
Lakewood, Colorado 80228
Longmont, Colorado 80501
Bridgeport, Connecticut 06606
Stamford, Connecticut 06905
Washington D.C., District of Columbia 20016
DeLand, Florida 32720
DeLand, Florida 32720
Doral, Florida 33172
Hallandale, Florida 33009
Hialeah, Florida 33012
Hollywood, Florida 33024
Hollywood, Florida 33024
Jupiter, Florida 33458
Lakeland, Florida 33803
Largo, Florida 33777
Maitland, Florida 32751
Miami Lakes, Florida 33016
New Port Richey, Florida 34652
Orlando, Florida 32819
Palmetto Bay, Florida 33157
Tampa, Florida 33613
Tampa, Florida 33615
Albany, Georgia 31707
Atlanta, Georgia 30329
Atlanta, Georgia 30331
Decatur, Georgia 30030
Decatur, Georgia 30030
Fayetteville, Georgia 30214
Savannah, Georgia 31406
Stockbridge, Georgia 30281
Meridian, Idaho 83642
Melrose Park, Illinois 60160
Valparaiso, Indiana 46383
Sioux City, Iowa 51106
Lenexa, Kansas 66212
Wichita, Kansas 67218
Louisville, Kentucky 40205
Versailles, Kentucky 40383
Baton Rouge, Louisiana 70809
Covington, Louisiana 70433
Kenner, Louisiana 70065
Lafayette, Louisiana 70508
Mandeville, Louisiana 70471
New Orleans, Louisiana 70115
New Orleans, Louisiana 70119
Prairieville, Louisiana 70769
Annapolis, Maryland 21401
Columbia, Maryland 21045
Rockville, Maryland 20854
Boston, Massachusetts 02115
Brookline, Massachusetts 02446
Methuen, Massachusetts 01844
Southfield, Michigan 48034
Southfield, Michigan 48076
Mankato, Minnesota 56001
Gulfport, Mississippi 39503
Chesterfield, Missouri 63005
Kansas City, Missouri 64116
Kansas City, Missouri 64151
Springfield, Missouri 65807
St Louis, Missouri 63141
Town and Country, Missouri 63017
Fremont, Nebraska 68025
Grand Island, Nebraska 68803
Lincoln, Nebraska 68510
Norfolk, Nebraska 68701
Omaha, Nebraska 68134
Omaha, Nebraska 68144
Papillion, Nebraska 68046
Las Vegas, Nevada 89119
Jersey City, New Jersey 07306
Albuquerque, New Mexico 87106
Albuquerque, New Mexico 87107
Rochester, New York 14609
Durham, North Carolina 27701
Raleigh, North Carolina 27607
Wilmington, North Carolina 28403
Winston-Salem, North Carolina 27157
Beachwood, Ohio 44122
Cincinnati, Ohio 45212
Cincinnati, Ohio 45242
Cincinnati, Ohio 45246
Edmond, Oklahoma 73013
Moore, Oklahoma 73160
Tulsa, Oklahoma 74133
Yukon, Oklahoma 73099
Medford, Oregon 97504
Portland, Oregon 97210
Horsham, Pennsylvania 19044
Philadelphia, Pennsylvania 19107
East Greenwich, Rhode Island 02818
Anderson, South Carolina 29621
Charleston, South Carolina 29407
Columbia, South Carolina 29204
North Charleston, South Carolina 29405
Spartanburg, South Carolina 29303
Union, South Carolina 29379
Hendersonville, Tennessee 37075
Abilene, Texas 79606
Austin, Texas 78745
Austin, Texas 78759
Beaumont, Texas 77706
Conroe, Texas 77384
Dallas, Texas 75230
Fort Worth, Texas 76135
Houston, Texas 77065
Houston, Texas 77081
Prosper, Texas 75078
Round Rock, Texas 78681
San Antonio, Texas 78207
San Antonio, Texas 78229
San Marcos, Texas 78666
Stephenville, Texas 76401
Sugar Land, Texas 77478
Sugar Land, Texas 77478
Sugar Land, Texas 77479
Tomball, Texas 77375
Bountiful, Utah 84010
Pleasant View, Utah 84404
Salt Lake City, Utah 84107
Salt Lake City, Utah 84117
South Jordan, Utah 84095
South Ogden, Utah 84405
West Jordan, Utah 84088
Charlottesville, Virginia 22911
Hampton, Virginia 23666
Richmond, Virginia 23226
Suffolk, Virginia 23435
Spokane, Washington 99218
More Details
- NCT ID
- NCT07266558
- Status
- Recruiting
- Sponsor
- ModernaTX, Inc.